Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Sonnet BioTherapeutics Holdings ( (SONN) ) is now available.
On September 26, 2025, Sonnet BioTherapeutics Holdings held its annual stockholders meeting where several key proposals were approved. These included the election of five directors to the board, the approval of executive compensation, the determination of the frequency for executive compensation approval, and the ratification of KPMG LLP as the independent public accounting firm for the fiscal year ending September 30, 2025. The approval of these proposals reflects the company’s ongoing commitment to corporate governance and operational transparency, potentially strengthening its position in the biotherapeutics market.
The most recent analyst rating on (SONN) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Sonnet BioTherapeutics Holdings stock, see the SONN Stock Forecast page.
Spark’s Take on SONN Stock
According to Spark, TipRanks’ AI Analyst, SONN is a Neutral.
Sonnet BioTherapeutics Holdings’ overall stock score is primarily impacted by its poor financial performance, with significant challenges in revenue generation, profitability, and cash flow. Technical analysis provides mixed signals, while valuation metrics are unattractive due to negative earnings. However, recent corporate events, including securing funding and a strategic merger, offer some positive outlook, slightly improving the overall score.
To see Spark’s full report on SONN stock, click here.
More about Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings, Inc. operates in the biotherapeutics industry, focusing on the development of innovative biologic medicines. The company is engaged in the research and development of targeted biologic drugs for cancer and other diseases, aiming to enhance treatment efficacy and patient outcomes.
Average Trading Volume: 4,475,820
Technical Sentiment Signal: Sell
Current Market Cap: $36.39M
Find detailed analytics on SONN stock on TipRanks’ Stock Analysis page.